Related Experiment Video
Updated: May 22, 2026

13:21
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
Chemically-blocked antibody microarray for multiplexed high-throughput profiling of specific protein glycosylation in
Chen Lu1, Joshua L Wonsidler, Jianwei Li
1Institute for Hepatitis and Virus Research.
Journal of Visualized Experiments : Jove
|May 17, 2012
Summary
This study presents a new, cost-effective antibody microarray method for protein glycosylation profiling. It simplifies the process, making it accessible for early disease biomarker detection.
Area of Science:
- Biochemistry
- Proteomics
- Glycomics
Background:
- Protein glycosylation is a prevalent post-translational modification influencing protein properties.
- Aberrant glycosylation is linked to cancer and other diseases, serving as a potential biomarker.
- Existing methods for glycosylation analysis are often complex and costly.
Purpose of the Study:
- To develop a practical, high-throughput method for protein glycosylation profiling.
- To reduce the time, cost, and equipment needed for glycosylation analysis.
- To enable early detection of diseases through glycosylation biomarker identification.
Main Methods:
- A multiplexed antibody microarray with chemically blocked antibodies was utilized.
- Immobilized antibodies captured glycoproteins from complex samples.
- Glycan detection was performed using biotinylated lectins and glycan binding proteins (GBPs), with detection via Dylight 549-Streptavidin.
Main Results:
- The protocol effectively profiles glycosylation patterns of specific proteins.
- The method significantly reduces requirements for time, cost, and laboratory equipment.
- Successful application demonstrated with an antibody panel and multiple lectins for comprehensive profiling.
Conclusions:
- This novel microarray protocol offers an accessible and efficient approach to protein glycosylation analysis.
- The method facilitates the development of glycosylation profiles for disease biomarker discovery.
- It addresses the need for a practical solution in clinical and laboratory settings.

